BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
203 results:

  • 1. Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
    Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
    Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radon exposure risks among residents proximal to gold mine tailings in Gauteng Province, South Africa: a cross-sectional preliminary study protocol.
    Mphaga KV; Utembe W; Rathebe PC
    Front Public Health; 2024; 12():1328955. PubMed ID: 38525346
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [circDDX17 targets miR-223-3p / RIP3 to regulate the proliferation and apoptosis of non-small cell lung cancer cells].
    Ding CZ; Wang GL; Jiang GQ; Wang HT; Liu YY; Zhang HL; Sun F; Wei L
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):239-248. PubMed ID: 38494770
    [No Abstract]    [Full Text] [Related]  

  • 4. Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
    Shan Y; Ding Z; Chen A; Cui Z
    J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102757. PubMed ID: 38403266
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors.
    Li Z; Zhao F; Wang G; Xue G; Wang N; Cao P; Hu Y; Wei Z; Ye X
    J Cancer Res Ther; 2023 Dec; 19(6):1669-1674. PubMed ID: 38156936
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Time trends of 16 modifiable risk factors on the burden of major cancers among the Chinese population.
    Li J; Song X; Ni Y; Zhu S; Chen W; Zhao Y; Yi J; Xia L; Nie S; Shang Q; Liu L
    Int J Cancer; 2024 Apr; 154(8):1443-1454. PubMed ID: 38126210
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. People With cancer Experience Worse Psychosocial and Financial Consequences of COVID-19 Compared With Other Chronic Disease Populations: Findings From the International COVID-19 Awareness and Response Evaluation Survey Study.
    Baydoun M; McLennan AIG; Carlson LE;
    JCO Glob Oncol; 2023 Sep; 9():e2300085. PubMed ID: 38060976
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
    Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
    Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.
    Zhao K; Xia C; Qiu M; Yang Z; Cui T; Song T; Li S; Mei H; Zheng Y; Wang H
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16679-16690. PubMed ID: 37725243
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The self-distillation trained multitask dense-attention network for diagnosing lung cancers based on CT scans.
    Chen L; Zhang Z
    Med Phys; 2024 Mar; 51(3):1738-1753. PubMed ID: 37715993
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Takeuchi E; Kondo K; Okano Y; Ichihara S; Kunishige M; Kadota N; Machida H; Hatakeyama N; Naruse K; Ogino H; Nokihara H; Shinohara T; Nishioka Y
    Thorac Cancer; 2023 Oct; 14(30):3042-3050. PubMed ID: 37669914
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer ≤ 2 cm: a systematic review and patient-level meta-analysis.
    Fong KY; Chan YH; Chia CML; Agasthian T; Lee P
    Updates Surg; 2023 Dec; 75(8):2343-2354. PubMed ID: 37563486
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.
    Chen YT; Yeh HC; Lee HY; Hsieh PF; Chou EC; Tsai YC; Hong JH; Huang CY; Jiang YH; Lee YK; Tseng JS; Yu CC; Chiang BJ; Hsueh TY; Wu CC; Tsai CY
    Asian J Surg; 2023 Aug; 46(8):3058-3065. PubMed ID: 37525448
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]    [Full Text] [Related]  

  • 16. Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
    He D; Yan M; Zhou Y; Ge H; Zhang X; Xu Y; Liu C; Ying K; Zhu Y
    Chest; 2024 Mar; 165(3):573-582. PubMed ID: 37499976
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.
    Felip E; Altorki N; Zhou C; Vallières E; Martínez-Martí A; Rittmeyer A; Chella A; Reck M; Goloborodko O; Huang M; Belleli R; McNally V; Srivastava MK; Bennett E; Gitlitz BJ; Wakelee HA
    Ann Oncol; 2023 Oct; 34(10):907-919. PubMed ID: 37467930
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection.
    Tan Y; Chen Z; Zeng Z; Wu S; Liu J; Zou S; Wang M; Liang K
    Microbiol Spectr; 2023 Aug; 11(4):e0000523. PubMed ID: 37436163
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Meta analysis of the second course of radiotherapy for recurrent esophageal cancer1.
    Xu P; Liu Y; Wu S; Cheng D; Sun Z
    J Xray Sci Technol; 2024; 32(1):141-155. PubMed ID: 37424494
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Infectious Complications in Patients With Non-small Cell lung cancer Treated With Immune Checkpoint Inhibitors.
    Guo MZ; Balaji A; Murray JC; Reuss JE; Steinke SM; Bennett K; Naidoo J
    Clin Lung Cancer; 2023 Nov; 24(7):613-620. PubMed ID: 37419702
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.